Entod Pharmaceuticals inaugurates R&D centre in Navi Mumbai, Health News, ET HealthWorld

[ad_1]

New Delhi: Entod Pharmaceuticals inaugurated its state-of-the-art research & development centre in Navi Mumbai. The DSIR-approved research laboratory is equipped with the latest molecular and formulation research tools, microbiology testing facilities, sterile batch production capacity, and high-end quality assurance/quality control analytical equipment.

The facility will focus on developing next-generation molecules using generative artificial intelligence (AI) platforms, particularly in the ophthalmic, ENT, paediatric, and skin care segments. Some of these molecules are expected to be indigenous to India.

Kishore Masurkar, Chairman, ENTOD Pharmaceuticals, stated, “By addressing unmet needs through innovation, we aim to make a lasting impact on patients not only in India but throughout the world.”

Dhananjay Thakur, Head, Quality Assurance, ENTOD Pharmaceuticals, added, “We envision this facility as a nucleus for transformative discoveries, where our team will work relentlessly to develop pharmaceutical solutions that redefine healthcare norms. This endeavour aligns with our larger mission of placing India at the forefront of pharmaceutical innovation globally.”

  • Published On Jan 31, 2024 at 02:27 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *